hsa-miR-145

ncRNA information

ncRNA name

hsa-miR-145

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

MRP1

Cancer information

Cancer name

Gallbladder Cancer

Cancer site

Gallbladder

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Up

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Studies on GBC cell lines suggested an increased cisplatin efficacy with miR-145 overexpression, whereas decreasing miR-145 expression reduced cisplatin sensitivity.

Tissue resource

fresh gallbladder cancer tissues and the corresponding noncancerous gallbladder tissues

human embryonic kidney cell lines HEK-293T

human gallbladder cancer cell lines of GBC-SD

human gallbladder cancer cell lines of SGC-996

Experiment

qRT-PCR,Western blot


Institute

Renji Hospital

American Type Culture Collection

the Academy of Life Sciences, Tongji University

Country

China

USA

Continent

Asia

Amercia